Michael King
banner
profmikeking.bsky.social
Michael King
@profmikeking.bsky.social
E.D. Butcher Chair of Bioengineering at Rice University. Associate Vice President for Research. Special Advisor to the Provost. Okinawan-American. “…one of the novelists of our time…”
Some good news: Prolactin sensitizes HT29 cells to TRAIL-mediated apoptosis. We tested the efficacy of our next generation dual affinity liposomes, based on immune cell delivery! #nanomedicine
January 22, 2026 at 6:24 PM
We built a computational model of the JAK2/STAT3 signaling pathway in response to late-pregnancy PRL levels!
Freely available at:
doi.org/10.5281/zeno...
January 22, 2026 at 6:24 PM
Cancer stem-associated markers and EMT increase with prolactin treatments.
January 22, 2026 at 6:24 PM
On the ATCC website, there are a total of 52 human colorectal cell lines available for cancer research applications. Only six are derived from female patients, highlighting that there is a disproportionate focus on male disease even at the level of research material availability.
January 22, 2026 at 6:24 PM
We found that pregnancy prolactin levels cause biphasic STAT3 phosphorylation and increased JAG1 and NICD expression.
January 22, 2026 at 6:24 PM
Pregnant colorectal cancer patients have larger tumors yet fewer options exist for anticancer interventions compared to non-pregnant colorectal cancer patients.
January 22, 2026 at 6:24 PM
Before we get into the science, this was my first opportunity to publish a second, “native language” abstract with the paper… so we were able to include a Spanish language version in lead author @MariaLCavestany ‘s mother tongue, muy bien! 🇪🇸
January 22, 2026 at 6:24 PM
Reposted by Michael King
Yesterday, Drs. Beraud and Marvin and Sarah organized a networking event during the @amsocmatbio.bsky.social Meeting in Baltimore.

We were delighted to connect with nearly 20 AIMBE Fellows, Emerging Leaders, and Council Representatives over an evening of food and conversation 🍤

(2/4)
November 18, 2025 at 10:16 PM